Alzheimer's Disease and Frontotemporal Dementias

A Review with Particular Reference to Pin1 Protein

 

Home

Pin1 Protein

Our Research

Our TEM Research

Our Publications

Research Team

Alzheimer's Disease

Tauopathies

About this Site

Literature:   A-K ; L-Z ; subject area

Search Site by Subject Area

Disclaimer/ Feedback

Links

Compiled by: Julian Thorpe

 

Corticobasal Degeneration (CBD)

N.B. This page is in the initial phases of construction, so I suggest you follow the external link below for more on this disease.

(external site links in italics )

See: The 'Institut National de la Sante et de la Recherche Medical' website for more detail on CBD, the NINDS CBD Information Page and the 'We Move' site ('the Internet's most comprehensive resource for movement disorder information ') 
Type: CBD is a sporadic, adult-onset neurodegenerative disease and belonging to the frontotemporal dementia (FTD) group. It is a movement disorder but there is also mild-to-moderate cognitive impairment.
Regions affected:   Cerebral cortex , deep cerebellar nuclei and substantia nigra .
Tau pathology: Neuronal:  intracytoplasmic PHF-like filaments and straight tubules. Glial :  intracytoplasmic PHF-like filaments and straight tubules; plaques in astrocytes ; 'coiled body' inclusions in astrocyte and oligodendrocyte white matter. Neuropil threads : extensive throughout grey and white matter.

Some Related References

Arai, T, Ikeda, K, Akiyama, H, Tsuchiya, K, Yagishita, S, Takamatsu, J (2001) Intracellular processing of aggregated tan differs between corticobasal degeneration and progressive supranuclear palsy. NEUROREPORT 12: 935-938

Arai, T, Ikeda, K, Akiyama, H, Shikamoto, Y, Tsuchiya, K, Yagishita, S, Beach, T, Rogers, J, Schwab, C, McGeer, PL (2001) Distinct isoforms of tau aggregated in neurons and glial cells in brains of patients with Pick's disease, corticobasal degeneration and progressive supranuclear palsy. ACTA NEUROPATHOLOGICA 101: 167-17

Arai, T, Ikeda, K, Akiyama, H, Tsuchiya, K, Iritani, S, Ishiguro, K, Yagishita, S, Oda, T, Odawara, T, Iseki, E (2003) Different immunoreactivities of the microtubule-binding region of tau and its molecular basis in brains from patients with Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration. ACTA NEUROPATHOLOGICA 105: 489-498  

Berry, RW, Sweet, AP, Clark, FA, Lagalwar, S, Lapin, BR, Wang, T, Topgi, S, Guillozet-Bongaarts, AL, Cochran, EJ, Bigio, EH, Binder, LI (2004) Tau epitope display in progressive supranuclear palsy and corticobasal degeneration. JOURNAL OF NEUROCYTOLOGY 33: 287-295

Cordato, NJ, Halliday, GM, McCann, H, Davies, L, Williamson, P, Fulham, M, Morris, JGL (2001) Corticobasal syndrome with tau pathology. MOVEMENT DISORDERS 16: 656-667

de Silva, R, Hardy, J, Crook, J, Khan, N, Graham, EA, Morris, CM, Wood, NW, Lees, AJ (2002) The tau locus is not significantly associated with pathologically confirmed sporadic Parkinson's disease . NEUROSCIENCE LETTERS 330: 201-203

Dickson, DW, Bergeron, C, Chin, SS, Duyckaerts, C, Horoupian, D, Ikeda, K, Jellinger, K, Lantos, PL, Lippa, CF, Mirra, SS, Tabaton, M, Vonsattel, JP, Wakabayashi, K, Litvan, I (2002) Office of rare diseases neuropathologic criteria forcorticobasal degeneration . JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY 61: 935-946

Ferrer, I, Barrachina, M, Puig, B (2002) Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration . ACTA NEUROPATHOLOGICA 104: 583-591

Ferrer, I, Blanco, R, Carmona, M, Ribera, R, Goutan, E, Puig, B, Rey, MJ, Cardozo, A, Vinals, F and Ribalta, T (2001) Phosphorylated map kinase (ERK1, ERK2) expression is associated with early tau deposition in neurones and glial cells, but not with increased nuclear DNA vulnerability and cell death, in Alzheimer disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration. BRAIN PATHOLOGY 11: 144-158

Forman, MS, Zhukareva, V, Bergeron, C, Chin, SSM, Grossman, M, Clark, C, Lee, VMY, Trojanowski, JQ (2002) Signature tau neuropathology in gray and white matter of corticobasal degeneration. AMERICAN JOURNAL OF PATHOLOGY 160: 2045-2053

Graham, NL, Bak, TH, Hodges, JR (2003) Corticobasal degeneration as a cognitive disorder. MOVEMENT DISORDERS 18: 1224-1232

Hattori, M, Hashizume, Y, Yoshida, M, Iwasaki, Y, Hishikawa, N, Ueda, R, Ojika, K (2003) Distribution of astrocytic plaques in the corticobasal degeneration brain and comparison with tuft-shaped astrocytes in the progressive supranuclear palsy brain. ACTA NEUROPATHOLOGICA 106: 143-149

Houlden, H, Baker, M, Morris, HR, MacDonald, N, Pickering-Brown, S, Adamson, J, Lees, AJ, Rossor, MN, Quinn, NP, Kertesz, A, Khan, MN, Hardy, J, Lantos, PL, George-Hyslop, PS, Munoz, DG, Mann, D, Lang, AE, Bergeron, C, Bigio, EH, Litvan, I, Bhatia, KP, Dickson, D, Wood, NW, Hutton, M (2001) Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. NEUROLOGY 56: 1702-1706

Ikeda, K, Akiyama, H, Arai, T, Tsuchiya, K (2002) Pick-body-like inclusions in corticobasal degeneration differ from Pick bodies in Pick's disease. ACTA NEUROPATHOLOGICA 103: 115-118

Ishizawa, K, Dickson, DW (2001) Microglial activation parallels system degeneration in progressive supranuclear palsy and corticobasal degeneration. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY 60: 647-657

Kasashima, S, Oda, Y (2003) Cholinergic neuronal loss in the basal forebrain and mesopontine tegmentum of progressive supranuclear palsy and corticobasal degeneration. ACTA NEUROPATHOLOGICA 105: 117-124

Katsuse, O, Iseki, E, Arai, T, Akiyama, H, Togo, T, Uchikado, H, Kato, M, de Silva, R, Lees, A, Kosaka, K (2003) 4-repeat tauopathy sharing pathological and biochemical features of corticobasal degeneration and progressive supranuclear palsy. ACTA NEUROPATHOLOGICA 106: 251-260

Kertesz, A (2003) Pick complex: An integrative approach to frontotemporal dementia - Primary progressive aphasia, corticobasal degeneration, and progressive supranuclear palsy. NEUROLOGIST 9: 311-317

Kleiner-Fisman, G, Black, SE, Lang, AE (2003) Neurodegenerative disease and the evolution of art: The effects of presumed corticobasal degeneration in a professional artist. MOVEMENT DISORDERS 18: 294-302

Monza, D, Ciano, C, Scaioli, V, Soliveri, P, Carella, F, Avanzini, G, Girotti, F (2003) Neurophysiological features in relation to clinical signs in clinically diagnosed corticobasal degeneration. NEUROLOGICAL SCIENCES 24: 16-23

Oyanagi, K, Tsuchiya, K, Yamazaki, M, Ikeda, K (2001) Substantia nigra in progressive supranuclear palsy, corticobasal degeneration, and Parkinsonism-dementia complex of Guam: Specific pathological features. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY 60: 393-402 

Pharr, V, Uttl, B, Stark, M, Litvan, I, Fantie, B, Grafman, J (2001) Comparison of apraxia in corticobasal degeneration and progressive supranuclear palsy. NEUROLOGY 56: 957-963

Piao, YS, Hayashi, S, Wakabayashi, K, Kakita, A, Aida, I, Yamada, M, Takahashi, H (2002) Cerebellar cortical tau pathology in progressive supranuclear palsy and corticobasal degeneration. ACTA NEUROPATHOLOGICA 103: 469-474

Sobrido, MJ, Abu-Khalil, A, Weintraub, S, Johnson, N, Quinn, B, Cummings, JL, Mesulam, MM, Geschwind, DH (2003) Possible association of the tau H1/H1 genotype with primary progressive aphasia. NEUROLOGY 60: 862-864

Stover, NP, Watts, RL (2001) Corticobasal degeneration. SEMINARS IN NEUROLOGY 21: 49-58

Uchihara, T, Nakamura, A, Yamazaki, M and Mori, O (2000) Tau-positive neurons in corticobasal degeneration and Alzheimer's disease - distinction by thiazin red and silver impregnations. ACTA NEUROPATHOLOGICA 100: 385-389

Zhukareva, V, Sundarraj, S, Mann, D, Sjogren, M, Blenow, K, Clark, CM, McKeel, DW, Goate, A, Lippa, CF, Vonsattel, JP, Growdon, JH, Trojanowski, JQ, Lee, VMY (2003) Selective reduction of soluble Tau proteins in sporadic and familial frontotemporal dementias: an international follow-up study. ACTA NEUROPATHOLOGICA 105: 469-476

Back to Top